title: Rosiglitazone inhibits RANTES expression by human epidermal keratinocytes.
authors.forename: Min
authors.initials: M
authors.lastname: Zhang
authors.forename: Jing
authors.initials: J
authors.lastname: Chen
authors.forename: Zaipei
authors.initials: Z
authors.lastname: Guo
authors.forename: Li
authors.initials: L
authors.lastname: Li
authors.forename: Yizhi
authors.initials: Y
authors.lastname: Zhang
authors.forename: Jianwei
authors.initials: J
authors.lastname: Li
mesh_terms: D002460:Cell Line; D018946:Chemokine CCL5 / Q000096:biosynthesis*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D015603:Keratinocytes / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000077154:Rosiglitazone; D015398:Signal Transduction; D045162:Thiazolidinediones / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D018946:Chemokine CCL5; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D000077154:Rosiglitazone; D007371:Interferon-gamma